An opportunity in a time of crisis: COVID-19 and the new pragmatism

June 29, 2020

 

 

Previous Article
What’s Around the Corner for FDA Inspections?
What’s Around the Corner for FDA Inspections?

There have been two recent activities from the U.S. Food and Drug Administration (FDA) that provide industr...

Next Article
FDA Expectations for Responding to Employees in Pharmaceutical Manufacturing Infected with COVID-19
FDA Expectations for Responding to Employees in Pharmaceutical Manufacturing Infected with COVID-19

Global manufacturers and regulators are facing new challenges during the SARS-CoV-2 pandemic to maintain su...